Cartesian Therapeutics Inc (RNAC)
EBITDA Margin
0.00%
Quarterly · Period ending:
RNAC EBITDA Margin
Latest reported0.00%period ending
Latest reported0.00%period ending
RNAC Quarterly EBITDA Margin (-518.47% → 0.00%)
Quarterly ebitda margin
High-resolution chart · PNG
RNAC ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0% | |
| -49,444.8718% | |
| -10,682.2598% | |
| -7,808.8496% | |
| 5,528.5235% | |
| -1,504.9091% | |
| 1,249.0119% | |
| -6,174.9354% | |
| 41.9554% | |
| -969.8801% | |
| -2,375.8287% | |
| -115.0969% | |
| -199.257% | |
| -347.7433% | |
| 39.613% | |
| -34.0995% | |
| 24.5996% | |
| 87.7555% | |
| 45.058% | |
| -4.1593% | |
| 28.3833% | |
| -214.2896% | |
| -121.2367% | |
| -198.6655% | |
| 0% | |
| 0% | |
| -196.0926% | |
| 0% | |
| -121,492.3077% | |
| -114,970% | |
| -1,558.1395% | |
| 0% | |
| 0% | |
| 0% | |
| -111,776.4706% | |
| -52,622.2222% | |
| -59,569.2308% | |
| -10,700% | |
| -460.8874% | |
| -690.458% | |
| -318.6415% | |
| -334.6743% | |
| -307.6851% | |
| -321.7175% | |
| -492.3139% | |
| -518.472% |